TABLE 3.
Subgroup analyses of pathological types for OS effects
| a. Squamous cell carcinoma | ||||
|---|---|---|---|---|
| NCRT + S | NCT + S | NRT + S | S | |
| NCRT + S | NCRT + S | 1.09 (0.88, 1.37) | 1.12 (0.81, 1.49) | 1.31 (1.11, 1.55) |
| NCT + S | 0.91 (0.73, 1.13) | NCT + S | 1.03 (0.74, 1.35) | 1.2 (1.01, 1.41) |
| NRT + S | 0.89 (0.67, 1.23) | 0.97 (0.74, 1.36) | NRT + S | 1.17 (0.92, 1.56) |
| S | 0.76 (0.64, 0.9) | 0.83 (0.71, 0.99) | 0.85 (0.64, 1.09) | S |
| b. Adenocarcinoma | ||||
|---|---|---|---|---|
| NCRT + S | NCT + S | S | ||
| NCRT + S | NCRT + S | 1.11 (0.82, 1.56) | 1.27 (0.96, 1.68) | |
| NCT + S | 0.9 (0.64, 1.22) | NCT + S | 1.14 (0.78, 1.61) | |
| S | 0.79 (0.6, 1.04) | 0.88 (0.62, 1.28) | S | |
Note: Statistically confident results are in bold.
Abbreviations: NCRT + S, neoadjuvant chemoradiotherapy followed by surgery; NCT + S, neoadjuvant chemotherapy followed by surgery; NRT + S, neoadjuvant radiotherapy followed by surgery; S, surgery.